Baili Pharmaceutical Group   Report issue

Founded: Chengdu China (1996)
Status: No NME R&D (1996)

Organization Overview

First Clinical Trial
2014
NCT02174042
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Guizhou Bailing Group Pharmaceutical Co Ltd | Sichuan Baili Pharmaceutical Co., Ltd.